<DOC>
	<DOCNO>NCT01214421</DOCNO>
	<brief_summary>To demonstrate whether tolvaptan modifies ADPKD progression measure change baseline ( trial 156-04-251 ) total kidney volume ( TKV ) renal function .</brief_summary>
	<brief_title>Open-Label Tolvaptan Study Subjects With ADPKD</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>Subjects successfully complete Phase 1 , 2 , 3 tolvaptan ADPKD renal impairment trial , confirm diagnosis ADPKD Subjects unable provide write informed consent Subjects ( men woman ) adhere reproductive precaution outline Informed Consent Form Subjects ( woman ) positive urine pregnancy test Subjects pregnant breastfeed Subjects unable take oral medication Subjects allergic reaction tolvaptan chemically related structure benzazepines ( benzazepril , conivaptan , fenoldopam mesylate mirtazapine ) Subjects disorder thirst recognition inability access fluid Subjects critical electrolyte imbalance , determine investigator Subjects risk significant hypovolemia , determine investigator Subjects anemia , determine investigator Subjects history substance abuse ( within last 3 year ) Subjects take experimental ( ie , nonmarketed ) therapy current participation another clinical drug device trial ; current participation offdrug followup period another ADPKD trial tolvaptan permit Efficacy Analysis Subjects unable complete MRI assessment ( eg , subject ferromagnetic prosthesis , aneurysm clip , severe claustrophobia ) Subjects take vasopressin antagonist ( outside previous participation tolvaptan trial ) Subjects unable comply antihypertensive important medical therapy Subjects advance diabetes Subjects take medication illness could confound endpoint assessment ( include take approved therapy purpose affect PKD cyst )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Kidney Disease</keyword>
	<keyword>ADPKD</keyword>
	<keyword>Autosomal Dominant Polycystic Kidney Disease</keyword>
	<keyword>Adult Polycystic Kidney Disease</keyword>
</DOC>